Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of renal nutrition

• Publication date

  2015-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.jrn.2015.02.006PMID 25802017PMCID PMC4469547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease

  2015cited by this paper
• L-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysis.

  2014cited by this paper
• Effect of chronic renal failure on the hepatic, intestinal, and renal expression of bile acid transporters.

  2014cited by this paper
• Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.

  2013cited by this paper
• Prealbumin is associated with visceral fat mass in patients receiving hemodialysis.

  2013cited by this paper
• Supplemental materials for: Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

  2013cited by this paper
• Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics.

  2013cited by this paper
• The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease.

  2013cited by this paper
• HDL Proteome in Hemodialysis Patients: A Quantitative Nanoflow Liquid Chromatography-Tandem Mass Spectrometry Approach

  2012cited by this paper
• Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

  2011cited by this paper
• Association of self-reported physical activity with laboratory markers of nutrition and inflammation: the Comprehensive Dialysis Study.

  2011cited by this paper
• The comprehensive dialysis study (CDS): a USRDS special study.

  2009cited by this paper
• Lipoprotein metabolism and lipid management in chronic kidney disease.

  2007cited by this paper
• HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Dialysis‐Related Carnitine Disorder

  2006cited by this paper
• Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.

  2006cited by this paper
• Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study.

  2004cited by this paper
• Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition.

  2004cited by this paper
• Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL 2 and HDL 3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study

  2004cited by this paper
• Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.

  2003cited by this paper
• Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients.

  2003cited by this paper
• Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review.

  2002cited by this paper
• Changes in plasma lecithin: cholesterol acyltransferase activity, HDL(2), HDL(3) amounts and compositions in patients with chronic renal failure after different times of hemodialysis.

  2002cited by this paper
• L‐Carnitine in Dialysis Patients

  2001cited by this paper
• In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene.

  2001cited by this paper
• Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients.

  2001cited by this paper
• Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities.

  1990cited by this paper
• Determination of body burden of uremic toxins.

  1984cited by this paper
• Malignant melanoma and fluorescent lighting.

  1982cited by this paper
• Biochemical profile or uremic breath.

  1977cited by this paper
• AMINE METABOLISM AND THE SMALL BOWEL IN URÆMIA

  1976cited by this paper
• Amine metabolism and the small bowel in uraemia.

  1976cited by this paper
• Urinary excretion of choline metabolites following choline administration in normals and patients with hepatobiliary diseases.

  1951cited by this paper

• Multi-omics analyses reveal that hesperidin ameliorates high-altitude pulmonary hypertension by restoring gut-lung axis homeostasis.

  2025cites this paper
• Trimethylamine-N-oxide promotes vascular aging via inhibiting GATA4 degradation in chronic kidney disease rats.

  2025cites this paper
• Microbial-Derived Uremic Toxins as a Factor of Vascular Remodeling in Patients Receiving Hemodialysis Treatment

  2025cites this paper
• Circulating trimethylamine N-oxide and cardiovascular, cerebral, and renal diseases including mortality: Umbrella review of published systematic reviews and meta-analyses.

  2025cites this paper
• Intermittent Fasting: Implications for Obesity-Related Colorectal Tumorigenesis.

  2025cites this paper
• Trimethylamine N-oxide as a potential prognostic biomarker for mortality in patients with COVID-19 disease.

  2025cites this paper
• Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease

  2024cites this paper
• The Associations Between Nutrition and Circulating Gut Microbiota-Derived Uremic Toxins in Patients Undergoing Kidney Replacement Therapy: an Observational, Cross-Sectional Study.

  2024cites this paper
• Deficiency of flavin-containing monooxygenase 3 protects kidney function after ischemia–reperfusion in mice

  2024cites this paper
• Human Gut Microbiota in Cardiovascular Disease.

  2024cites this paper
• TMAO Impairs Mouse Aortic Vasodilation by Inhibiting TRPV4 Channels in Endothelial Cells

  2024cites this paper
• Gut microbiota metabolites and risk of major adverse cardiovascular events and death: A systematic review and meta-analysis

  2024cites this paper
• Sweet, bloody consumption – what we eat and how it affects vascular ageing, the BBB and kidney health in CKD

  2024cites this paper
• Plasma concentration of TMAO is an independent predictor of adverse outcomes in patients after acute myocardial infarction

  2023cites this paper
• Plasma Trimethylamine N-Oxide Levels Are Associated with Poor Kidney Function in People with Type 2 Diabetes

  2023influential citation
• N-óxido de trimetilamina e doenças renais: o que sabemos?

  2023cites this paper
• Trimethylamine N-oxide and kidney diseases: what do we know?

  2023cites this paper
• Time-dependent specific molecular signatures of inflammation and remodelling are associated with trimethylamine-N-oxide (TMAO)-induced endothelial cell dysfunction

  2023cites this paper
• An Overview of Chronic Kidney Disease Pathophysiology: The Impact of Gut Dysbiosis and Oral Disease

  2023cites this paper
• Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?

  2023cites this paper
• Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD).

  2023cites this paper
• Gut Microbiota Perturbation in Early Life Could Influence Pediatric Blood Pressure Regulation in a Sex-Dependent Manner in Juvenile Rats

  2023cites this paper
• Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis

  2023cites this paper
• The Association of Circulating L-Carnitine, γ-Butyrobetaine and Trimethylamine N-Oxide Levels with Gastric Cancer

  2023cites this paper
• Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics

  2023cites this paper
• Consumption of Fish in Chronic Kidney Disease - A Matter of Depth.

  2023cites this paper
• The role of gut-dependent molecule trimethylamine N-oxide as a novel target for the treatment of chronic kidney disease

  2023cites this paper
• Molecular interactions between the intestinal microbiota and the host

  2022cites this paper
• Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy

  2022cites this paper
• Higher serum trimethylamine-N-oxide levels are associated with increased abdominal aortic calcification in hemodialysis patients

  2022cites this paper
• Trimethylamine N-Oxide as a potential risk factor for non-communicable diseases: A systematic review.

  2022cites this paper
• Implications of trimethylamine N-oxide (TMAO) and Betaine in Human Health: Beyond Being Osmoprotective Compounds

  2022cites this paper
• The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study

  2022cites this paper
• TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

  2022cites this paper
• Plasmatic trimethylamine N-oxide and its relation to stroke: A systematic review and dose-response meta-analysis

  2022cites this paper
• Classification of trimethylamine-N-oxide, a cardiometabolic disease biomarker, by Raman spectroscopy and support vector machines

  2022cites this paper
• Association between trimethylamine N‐oxide and prognosis of patients with acute myocardial infarction and heart failure

  2022cites this paper
• Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults

  2022cites this paper
• High plasma levels of betaine, a trimethylamine N‐Oxide‐related metabolite, are associated with the severity of cirrhosis

  2022cites this paper
• Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?

  2022cites this paper
• Circulating Trimethylamine-N-Oxide and Risk of All-Cause and Cardiovascular Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• Gut microbiota–derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis

  2022cites this paper
• Gut microbiota metabolic characteristics in coronary artery disease patients with hyperhomocysteine

  2022cites this paper
• Balancing the Equation: A Natural History of Trimethylamine and Trimethylamine-N-oxide.

  2022cites this paper
• Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial

  2021cites this paper
• Cancer Related Anemia: An Integrated Multitarget Approach and Lifestyle Interventions

  2021cites this paper
• Gut Metabolite Trimethylamine N-Oxide Protects INS-1 β-Cell and Rat Islet Function under Diabetic Glucolipotoxic Conditions

  2021cites this paper
• Association of Trimethylamine-N-Oxide Levels with Risk of Cardiovascular Disease and Mortality among Elderly Subjects: A Systematic Review and Meta-Analysis

  2021cites this paper
• Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis

  2021cites this paper
• Paradox of trimethylamine-N-oxide, the impact of malnutrition on microbiota-derived metabolites and septic patients

  2021cites this paper
• Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis.

  2021cites this paper
• The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It’s Not All Bad

  2021cites this paper
• A Metabolomic Analysis of the Sex-Dependent Hispanic Paradox

  2021cites this paper
• Elevated levels of gut microbiota dependent trimethylamine N-oxide: An indicator of cardiovascular disease

  2021cites this paper
• Utility of SIFT-MS to evaluate volatile organic compounds in nephropathic patients’ breath

  2021cites this paper
• Circulating Trimethylamine N-Oxide Is Associated with Increased Risk of Cardiovascular Mortality in Type-2 Diabetes: Results from a Dutch Diabetes Cohort (ZODIAC-59)

  2021cites this paper
• Could the Gut Microbiota Serve as a Therapeutic Target in Ischemic Stroke?

  2021cites this paper
• Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization

  2021influential citation
• Trimethylamine N-oxide (TMAO): a new attractive target to decrease cardiovascular risk

  2021cites this paper
• Gut Microbiota-Derived Trimethylamine N-Oxide and Kidney Function: A Systematic Review and Meta-Analysis.

  2021influential citation
• Trimethylamine N-Oxide and mortality in hemodialysis patients: like a mystery

  2021cites this paper
• Gut microbiota and their metabolites in cardiovascular disease.

  2021cites this paper
• The roles of microbial products in the development of colorectal cancer: a review

  2021cites this paper
• Metabolomics Analysis of Viral Therapeutics.

  2021cites this paper
• Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.

  2021cites this paper
• Elevated Serum Trimethylamine N-Oxide Levels Are Associated with Mortality in Male Patients on Peritoneal Dialysis

  2021cites this paper
• Trimethylamine-N-oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis

  2020cites this paper
• Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals

  2020cites this paper
• Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system

  2020cites this paper
• Selected cardiovascular risk factors in early stages of chronic kidney disease

  2020cites this paper
• Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events

  2020cites this paper
• Gut microbiota: a promising target against cardiometabolic diseases

  2020cites this paper
• Microbiome and Cardiovascular Disease.

  2020cites this paper
• Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease

  2020cites this paper
• Comprehensive Examination of the Mouse Lung Metabolome Following Mycobacterium tuberculosis Infection Using a Multiplatform Mass Spectrometry Approach

  2020cites this paper
• Trimethylamine N-Oxide in Relation to Cardiometabolic Health—Cause or Effect?

  2020cites this paper
• Novel findings of the association between gut microbiota–derived metabolite trimethylamine N-oxide and inflammation: results from a systematic review and dose-response meta-analysis

  2020cites this paper
• Gut microbiota-dependent trimethylamine N-oxide and all-cause mortality: Findings from an updated systematic review and meta-analysis.

  2020cites this paper
• Plant-Based Diets, the Gut Microbiota, and Trimethylamine N-Oxide Production in Chronic Kidney Disease: Therapeutic Potential and Methodological Considerations.

  2020cites this paper
• Plasma Trimethylamine N-Oxide and Its Precursors: Population Epidemiology, Parent–Child Concordance, and Associations with Reported Dietary Intake in 11- to 12-Year-Old Children and Their Parents

  2020cites this paper
• Trimethylamine N-oxide: heart of the microbiota–CVD nexus?

  2020cites this paper
• TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis

  2020cites this paper
• EFFECTS OF TRIMETHYLAMINE N-OXIDE ON MOUSE EMBRYONIC STEM CELL PROPERTIES

  2020cites this paper
• Effects of gut microbial metabolite trimethylamine N-oxide (TMAO) on platelets and endothelial cells

  2020cites this paper
• Gut Microbiota in Hypertension and Atherosclerosis: A Review

  2020cites this paper
• Association of trimethylamine N-Oxide with cardiovascular and all-cause mortality in hemodialysis patients

  2020cites this paper
• Review: Uremic Toxins and Gut Microbiome

  2020cites this paper
• Trimethylamine N-oxide (TMAO) Is not Associated with Cardiometabolic Phenotypes and Inflammatory Markers in Children and Adults

  2020cites this paper
• Trimethylamine-N-Oxide: Heart of the microbiota- cardiovascular disease nexus?

  2020cites this paper
• Metabolic Synergy to Uremic Toxicity: A Tale of Symbiosis and Dysbiosis in CKD

  2019cites this paper
• The Pathophysiology of Uremia

  2019cites this paper
• Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights.

  2019cites this paper
• Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with End-stage Kidney Disease Receiving Maintenance Hemodialysis.

  2019cites this paper
• Assessing Clinical Relevance of Uremic Toxins.

  2019cites this paper
• Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism.

  2019cites this paper
• Serum gut microbe-dependent trimethylamine N-oxide improves the prediction of future cardiovascular disease in a community-based general population.

  2019cites this paper
• Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease

  2019cites this paper
• Plasma Kinetics of Choline and Choline Metabolites After A Single Dose of SuperbaBoostTM Krill Oil or Choline Bitartrate in Healthy Volunteers

  2019cites this paper
• Database Assisted Globally Optimized Targeted Mass Spectrometry (dGOT-MS): Broad and Reliable Metabolomics Analysis with Enhanced Identification.

  2019cites this paper
• Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate

  2019cites this paper